The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.

Published in: CNS neuroscience & therapeutics (2024)

accumulation that could suggest a novel mechanism of neuroprotection.

Keyphrases